Cargando…
Canagliflozin mitigates ferroptosis and improves myocardial oxidative stress in mice with diabetic cardiomyopathy
Canagliflozin (Cana), an anti-diabetes drug belongs to sodium-glucose cotransporter 2 inhibitor, is gaining interest because of its extra cardiovascular benefits. Ferroptosis is a new mode of cell death, which can promote the occurrence of diabetic cardiomyopathy (DCM). Whether Cana can alleviate DC...
Autores principales: | Du, Shuqin, Shi, Hanqiang, Xiong, Lie, Wang, Ping, Shi, Yanbo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9616119/ https://www.ncbi.nlm.nih.gov/pubmed/36313744 http://dx.doi.org/10.3389/fendo.2022.1011669 |
Ejemplares similares
-
Susceptibility of cervical cancer to dihydroartemisinin-induced ferritinophagy-dependent ferroptosis
por: Shi, Hanqiang, et al.
Publicado: (2023) -
Canagliflozin mitigates ferroptosis and ameliorates heart failure in rats with preserved ejection fraction
por: Ma, Sai, et al.
Publicado: (2022) -
Myocardial protection of S-nitroso-L-cysteine in diabetic cardiomyopathy mice
por: Peng, Lulu, et al.
Publicado: (2022) -
Ferroptosis: roles and molecular mechanisms in diabetic cardiomyopathy
por: Zhao, Yangting, et al.
Publicado: (2023) -
Signaling Pathways Related to Oxidative Stress in Diabetic Cardiomyopathy
por: Peng, Meng-ling, et al.
Publicado: (2022)